American Society of Hirudotherapy

Smart Library

Faceted search across all 5 registries. Filter by registry type, evidence level, or safety domain.

Curated knowledge library: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.Reference collection: Content is historical, educational, or biographical reference material — not a clinical recommendation.

New to hirudotherapy? Start here

This library indexes the full evidence base. For orientation, begin with the core guides:

Conditions

20

Venous Congestion in Surgical Flaps

Tier A

FDA-cleared application: medicinal leech therapy to relieve venous congestion in compromised tissue flaps awaiting vascular ingrowth.

FDA-cleared device indication: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.FDA-cleared regulatory context

Microsurgical Replantation (Digit / Ear / Scalp)

Tier A

FDA-cleared application: post-replantation venous decompression in digits, ears, scalp, and partial avulsion injuries.

FDA-cleared device indication: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.FDA-cleared regulatory context

Breast Reconstruction Flap Salvage

Tier A

FDA-cleared application: venous decompression of compromised DIEP, TRAM, and latissimus dorsi flaps in post-mastectomy reconstruction.

FDA-cleared device indication: FDA has cleared Hirudo medicinalis as a medical device (K040187, June 21 2004) for venous congestion in surgical flaps. Other uses are off-label or investigational.FDA-cleared regulatory context

Peripheral Artery Disease (Claudication, Investigational)

Tier C

Highly investigational adjunct for intermittent claudication; ABI must be assessed first; critical limb ischemia is an absolute contraindication.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Erythromelalgia (Investigational)

Tier C

Highly investigational use for primary or secondary erythromelalgia (red, hot, painful extremities); no clinical study of leech therapy was identified.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Complex Regional Pain Syndrome (Type I, Investigational)

Tier C

Highly investigational adjunct for CRPS Type I; one case report and no controlled study identified; multidisciplinary pain management and physiotherapy remain primary.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Phantom Limb Pain (Investigational)

Tier C

Highly investigational adjunct for chronic phantom limb pain; no clinical study identified; mirror therapy and gabapentinoids remain primary.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Spasticity Post-Spinal Cord Injury (Investigational Adjunct)

Tier C

Investigational adjunct for muscular spasticity after SCI; no clinical study identified; baclofen (oral or intrathecal) and physiotherapy remain primary.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Type 2 Diabetes Microvascular Complications (Investigational)

Tier C

Investigational adjunct for microvascular complications of type 2 diabetes; one small randomized trial in neuropathy plus case reports; glycemic control and standard pharmacotherapy remain primary.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.RCT

Chronic Radiation Dermatitis (Investigational)

Tier C

Highly investigational adjunct for chronic radiation dermatitis after oncology completion; no clinical report of leech therapy was identified; standard skin care and dermatology referral remain primary.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Buerger's Disease / Thromboangiitis Obliterans (Investigational Adjunct)

Tier C

Investigational adjunct for Buerger's disease; absolute tobacco cessation is the only disease-modifying intervention; iloprost and surgical sympathectomy for selected cases.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Mechanistic

Diabetic Peripheral Neuropathy (Investigational Adjunct)

Tier C

Investigational adjunct for symptomatic diabetic peripheral neuropathy; glycemic control, foot care, and pharmacotherapy (duloxetine, pregabalin, gabapentin) remain evidence-based.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.RCT

Nail Psoriasis (Investigational Adjunct)

Tier C

Investigational adjunct for nail psoriasis; topical corticosteroids, intralesional steroid, and (for severe disease) systemic biologics remain evidence-based.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Asymptomatic Mild-to-Moderate Carotid Stenosis (Investigational Adjunct)

Tier C

Investigational adjunct for asymptomatic mild-to-moderate carotid stenosis; risk-factor management (statin, antiplatelet, blood pressure, smoking cessation, glycemic control) remains evidence-based; symptomatic or high-grade disease requires vascular surgery referral.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Cervical Spondylotic Myelopathy Pain (Investigational Adjunct)

Tier C

Investigational adjunct for paraspinal pain in mild cervical spondylotic myelopathy; surgical decompression remains evidence-based when myelopathic signs progress; conservative management for mild non-progressive disease.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Chronic Recurrent Chilblains (Pernio, Investigational Adjunct)

Tier C

Investigational adjunct for chronic recurrent chilblains; cold avoidance, smoking cessation, calcium channel blockers (nifedipine), and topical corticosteroids remain evidence-based.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Hailey-Hailey Disease (Benign Familial Pemphigus, Investigational Adjunct)

Tier C

Investigational adjunct for refractory Hailey-Hailey disease; topical corticosteroids, topical antibiotics, topical calcineurin inhibitors, oral antibiotics, and (refractory) botulinum toxin or surgical interventions remain evidence-based.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Hand-Arm Vibration Syndrome (Investigational Adjunct)

Tier C

Investigational adjunct for vascular and neurosensory components of hand-arm vibration syndrome; cessation of vibration exposure, smoking cessation, calcium channel blockers for vascular component, and gabapentinoids for neurosensory pain remain evidence-based.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Insufficient evidence

Livedoid Vasculopathy (Investigational Adjunct)

Tier C

Investigational adjunct for livedoid vasculopathy; no clinical leech study was identified, and anticoagulation and IVIG remain guideline first-line.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

Necrobiosis Lipoidica (Investigational Adjunct)

Tier C

Investigational adjunct for stable non-ulcerated necrobiosis lipoidica; no clinical leech study was identified; topical corticosteroids remain first-line.

Investigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Case report

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Smart Library — Faceted Search Across All Registries | ASH